CartiHeal logo — www.cartiheal.com

CartiHeal

www.cartiheal.com

Founded 2009 Israel Israel 19 employees Corporate Round Total: $41.50M Health Care, Manufacturing +1

General Information

Company Name CartiHeal
Founded Year 2009
Location Israel Israel +2
Employees 19
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Corporate Round
Social

Get notified when CartiHeal moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CartiHeal

CartiHeal is an Israel-based medical device company that focuses on developing proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. The company's flagship product, Agili-C, is a cell-free, off-the-shelf implant that has received a CE mark for use in cartilage and osteochondral defects. The implant has undergone trials in leading centers in Europe and Israel, with over 400 patients benefiting from its application to treat a wide spectrum of cartilage lesions, from single focal lesions to multiple and large defects in patients suffering from osteoarthritis. In July 2020, CartiHeal secured a $15.00MCorporate Round investment from Bioventus. The company was founded in 2009 and operates in the Health Care and Manufacturing industries. Although the Agili-C implant is CE marked, it is important to note that in the United States, it is limited for use in an IDE study and is not available for commercial sale. With its innovative products and successful trials, CartiHeal is positioned to make a significant impact in the treatment of cartilage and osteochondral defects.

Taxonomy: medical device, cartilage regeneration, cartilage repair, osteochondral defects, hyaline cartilage, regenerative medicine, CE marked implant, osteochondral implant, cell-free implant, minimally-invasive surgery, orthopedic surgery, traumatic joint injuries, osteoarthritis treatment, Israeli healthcare innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round $15.00M 1 16 Jul 2020
Corporate Round $2.50M 1 01 Feb 2018
Series D $3.00M 1 01 Feb 2015
Venture Round $5.00M 3 29 Oct 2013
Venture Round $10.00M 3 09 Jul 2012

View All 8 Funding Rounds

CartiHeal Alternatives & Competitors

CartiHeal vs
Nanochon
Nanochon United States

Nanochon is developing highly effective, minimally invasive and low cost solutions for cartilage los...

Non Equity Assistance
12 employees
Biotechnology, Medical Devices
CartiHeal vs

Dedicated to crafting innovative medical devices that meet clinical needs and enhance patient outcom...

Angel
Biotechnology, Health Care
CartiHeal vs

We aim to reduce patient suffering from meniscus and articular cartilage injury or degeneration by c...

Series Unknown
9 employees
Biotechnology, Health Care

FAQ About CartiHeal

www.cartiheal.com
CartiHeal was founded in 2009.
CartiHeal is headquartered in Israel.
CartiHeal operates in the following industries: Health Care, Manufacturing, Medical Devices.
CartiHeal has approximately 19 employees.
CartiHeal has completed 8 funding rounds, raising a total of $41.50M. The latest funding stage is Corporate Round.
Top alternatives and competitors to CartiHeal include Nanochon, ABS Corporation, ORTEQ Sports Medicine, Intrinsic Therapeutics, Inc, Regentis Biomaterials. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CartiHeal and Nanochon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CartiHeal and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy